2010 in a nutshell

2010 was a year of established projects coming to fruition and the start of the last and highly promising research projects in the implementation of the first phase of the programme. At the heart of our activities, this year was a reflection on the future road to take through internal and external evaluation and discussion with our stakeholders. Our commitment to fostering partnership and collaboration was especially rewarded by the launch of two new networks of excellence, thus completing a set of four operational regional research networks.

• Networks of Excellence in place for all regions

  In the first quarter of 2010 EDCTP-funded networks of excellence were launched in Eastern Africa and Southern Africa. Now each region of sub-Saharan Africa has its own network. Read More

• EDCTP: impact assessment and future plans

  The process of evaluation of the EDCTP programme started in 2009 with the internal assessment commissioned to the Swiss Centre for International Health of the Swiss Tropical Institute, followed by an independent external evaluation commissioned by the European Commission. Read More

• New clinical trials

  EDCTP-funded clinical trial of new TB-drug SQ109 supported; TB-vaccine AERAS-402/Crucell Ad35: phase II clinical trial started in Kenya in 2010; Malaria vaccine GMZ2: AMANET launched phase II clinical trial in November 2010; ad Malaria in pregnancy clinical trials making headway. Read More

• EDCTP General Assembly

  Hannah Akuffo elected as new Chair; GA adds Deputy GA members; and incorporation of African representation.
  Read More